158
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Development of non-peptide ACE inhibitors as novel and potent cardiovascular therapeutics: An in silico modelling approach

, , , , , , , & show all
Pages 503-515 | Received 21 Apr 2018, Published online: 30 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sapan Shah, Dinesh Chaple, Vijay H. Masand, Magdi E.A Zaki, Sami A. Al-Hussain, Ashish Shah, Sumit Arora, Rahul Jawarkar & Mohammad Tauqeer. (2023) In silico study to recognize novel angiotensin-converting-enzyme-I inhibitors by 2D-QSAR and constraint-based molecular simulations. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-20.
Read now

Articles from other publishers (6)

Vanja P. Ničkčović, Gordana R. Nikolić, Biserka M. Nedeljković, Nebojša Mitić, Snežana Filipović Danić, Jadranka Mitić, Zoran Marčetić, Dušan Sokolović & Aleksandar M. Veselinović. (2022) In silico approach for the development of novel antiviral compounds based on SARS-COV-2 protease inhibition. Chemical Papers 76:7, pages 4393-4404.
Crossref
Maja Zivkovic, Marko Zlatanovic, Nevena Zlatanovic, Mladjan Golubović & Aleksandar M. Veselinović. (2020) The Application of the Combination of Monte Carlo Optimization Method based QSAR Modeling and Molecular Docking in Drug Design and Development. Mini-Reviews in Medicinal Chemistry 20:14, pages 1389-1402.
Crossref
Julio Caballero. (2020) Considerations for Docking of Selective Angiotensin-Converting Enzyme Inhibitors. Molecules 25:2, pages 295.
Crossref
Andrey A. Toropov & Alla P. Toropova. (2019) QSAR as a random event: criteria of predictive potential for a chance model. Structural Chemistry 30:5, pages 1677-1683.
Crossref
Mája Polakovičová & Josef Jampílek. (2019) Advances in Structural Biology of ACE and Development of Domain Selective ACE-inhibitors. Medicinal Chemistry 15:6, pages 574-587.
Crossref
Snezana Ćirić Zdravković, Milan Pavlović, Svetlana Apostlović, Goran Koraćević, Sonja Šalinger Martinović, Dragana Stanojević, Dušan Sokolović & Aleksandar M. Veselinović. (2019) Development and design of novel cardiovascular therapeutics based on Rho kinase inhibition—In silico approach. Computational Biology and Chemistry 79, pages 55-62.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.